Lilly Announces New $3.5 Billion Manufacturing Site in Pennsylvania
Eli Lilly announced Friday that it will invest over $3.5 billion in a new injectable medicine and device manufacturing facility in Lehigh Valley, Pennsylvania. The site is expected to be operational in 2031. “To meet … Read More